| 03/28 | Renovacor Names New CFO | MT |
| 2021 | Pacira BioSciences Logs Higher Exparel, Iovera Sales in November | MT |
| 2021 | NORTH AMERICAN MORNING BRIEFING : Stock Futures -3- | DJ |
| 2021 | Northland Securities Downgrades Flexion Therapeutics to Market Perform From Outperform,.. | MT |
| 2021 | FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Ma.. | AQ |
| 2021 | FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Composite Index | CI |
| 2021 | FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Global BMI Index | CI |
| 2021 | FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P TMI Index | CI |
| 2021 | FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Biotechnology Index | CI |
| 2021 | FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A.. | AQ |
| 2021 | Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont.. | CI |
| 2021 | SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Flexion Thera.. | PR |
| 2021 | SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its.. | PR |
| 2021 | NORTH AMERICAN MORNING BRIEFING : Stock Futures -3- | DJ |
| 2021 | FLEXION THERAPEUTICS : HC Wainwright Downgrades Flexion Therapeutics to Neutral From Buy, .. | MT |
| 2021 | SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its.. | PR |
| 2021 | NORTH AMERICAN MORNING BRIEFING : Stock Futures -3- | DJ |
| 2021 | FLEXION THERAPEUTICS INVESTOR ALERT : Kahn Swick & Foti, LLC Investigates Adequacy of Pri.. | BU |
| 2021 | FLEXION THERAPEUTICS : BMO Capital Downgrades Flexion Therapeutics to Market Perform Ratin.. | MT |
| 2021 | FLEXION THERAPEUTICS : Credit Suisse Downgrades Flexion Therapeutics to Neutral from Outpe.. | MT |
| 2021 | FLEXION THERAPEUTICS : Credit Suisse Downgrades Flexion Therapeutics to Neutral From Outpe.. | MT |
| 2021 | FLEXION THERAPEUTICS : Raymond James Downgrades Flexion Therapeutics to Market Perform Fro.. | MT |
| 2021 | FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Results of Operatio.. | AQ |
| 2021 | Health Care Stocks Sliding in Late Monday Trading | MT |
| 2021 | SECTOR UPDATE : Health Care | MT |
| 2021 | SHAREHOLDER ALERT : Ademi LLP investigates whether Flexion Therapeutics, Inc. has obtained.. | PR |
| 2021 | Top Midday Gainers | MT |
| 2021 | FLEXION MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the S.. | BU |
| 2021 | Health Care Stocks Trade Lower Premarket Monday | MT |
| 2021 | Wall Street Declines on Soaring Energy Prices | MT |
| 2021 | FLEXION THERAPEUTICS : Agrees to Be Acquired by Pacira BioSciences; Shares Soar Pre-Bell | MT |
| 2021 | Top Premarket Gainers | MT |
| 2021 | Pacira adds non-opioid pain drugs with $427.5 million Flexion buy | RE |
| 2021 | PACIRA BIOSCIENCES : to buy Flexion for $427.5 million | RE |
| 2021 | FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GL |
| 2021 | FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Biotechnology Select Industry.. | CI |
| 2021 | Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Co.. | GL |
| 2021 | FLEXION THERAPEUTICS : to Present at the Wells Fargo 2021 Virtual Healthcare Conference | AQ |
| 2021 | FLEXION THERAPEUTICS : Announces Inclusion of ZILRETTA in American Academy of Orthopaedic .. | AQ |
| 2021 | Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare Conference | GL |
| 2021 | FLEXION THERAPEUTICS : Announces Inclusion of ZILRETTA® in American Academy of Orthopaedic.. | AQ |
| 2021 | Flexion Therapeutics Announces Inclusion of ZILRETTA® in American Academy of Orthopaedi.. | CI |
| 2021 | FLEXION THERAPEUTICS : Expands Early Stage Study of Drug Candidate for Post-Operative Pain.. | MT |
| 2021 | FLEXION THERAPEUTICS : Announces Expansion of Phase 1b Trial Investigating FX301 for the M.. | AQ |
| 2021 | Flexion Therapeutics Announces Expansion of Phase 1B Trial Investigating Fx301 for the .. | CI |
| 2021 | FLEXION THERAPEUTICS : Announces Publication of Results from Phase 2 Pharmacokinetics (PK).. | AQ |
| 2021 | Flexion Therapeutics, Inc. Announces Publication of Results from Phase 2 Pharmacokineti.. | CI |
| 2021 | FLEXION THERAPEUTICS : Goldman Sachs Adjusts Price Target on Flexion Therapeutics to $6 Fr.. | MT |
| 2021 | FLEXION THERAPEUTICS : Needham Adjusts Flexion Therapeutics' Price Target to $18 From $20,.. | MT |
| 2021 | FLEXION THERAPEUTICS : Q2 2021 Commercial Metrics Overview - August 4, 2021 | PU |
| 2021 | FLEXION THERAPEUTICS : Reports Second-Quarter 2021 Financial Results and Recent Business H.. | PU |
| 2021 | FLEXION THERAPEUTICS : Q2 Earnings Snapshot | AQ |
| 2021 | TRANSCRIPT : Flexion Therapeutics, Inc., Q2 2021 Earnings Call, Aug 04, 2021 | CI |
| 2021 | FLEXION THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES.. | AQ |
| 2021 | Flexion Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 3.. | CI |
| 2021 | FLEXION THERAPEUTICS : Earnings Flash (FLXN) FLEXION THERAPEUTICS Reports Q2 Revenue $28.2.. | MT |
| 2021 | FLEXION THERAPEUTICS : Reports Second-Quarter 2021 Financial Results and Recent Business H.. | AQ |
| 2021 | Flexion Therapeutics, Inc. Reiterates Net Sales Guidance for the Full Year 2021 | CI |
| 2021 | FLEXION THERAPEUTICS : to Report Second-Quarter 2021 Financial Results on August 4, 2021 | AQ |
| 2021 | FLEXION THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2021 | Flexion Therapeutics, Inc. Announces Resignation of Patrick Mahaffy as A Member and Cha.. | CI |
| 2021 | Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors | GL |
| 2021 | Flexion Therapeutics, Inc. Announces Appointment of Utpal Koppikar to Board of Director.. | CI |
| 2021 | FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4) | AQ |
| 2021 | Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GL |
| 2021 | FLEXION THERAPEUTICS INC : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 2021 | FLEXION THERAPEUTICS : Q1 Earnings Snapshot | AQ |
| 2021 | Flexion Therapeutics to Present at the 2021 Raymond James Human Health Innovation Confe.. | GL |
| 2021 | FLEXION THERAPEUTICS : Names New Chief Medical Officer | MT |
| 2021 | Flexion Therapeutics Announces Appointment of William T. Andrews, M.D., F.A.C.P., as Ch.. | GL |
| 2021 | Flexion Therapeutics, Inc. Appoints William T. Andrews as Chief Medical Officer, Effect.. | CI |
| 2021 | TRANSCRIPT : Flexion Therapeutics, Inc. Presents at Goldman Sachs 42nd Annual Global Healt.. | CI |
| 2021 | FLEXION THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4) | AQ |
| 2021 | Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GL |
| 2021 | Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virt.. | GL |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
